Growth Metrics

Fortress Biotech (FBIO) Operating Expenses: 2009-2024

Historic Operating Expenses for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to $168.1 million.

  • Fortress Biotech's Operating Expenses fell 33.44% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.7 million, marking a year-over-year decrease of 9.98%. This contributed to the annual value of $168.1 million for FY2024, which is 25.92% down from last year.
  • As of FY2024, Fortress Biotech's Operating Expenses stood at $168.1 million, which was down 25.92% from $226.9 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Operating Expenses registered a high of $279.3 million during FY2022, and its lowest value of $139.9 million during FY2020.
  • Moreover, its 3-year median value for Operating Expenses was $226.9 million (2023), whereas its average is $224.7 million.
  • In the last 5 years, Fortress Biotech's Operating Expenses soared by 83.98% in 2021 and then dropped by 25.92% in 2024.
  • Over the past 5 years, Fortress Biotech's Operating Expenses (Yearly) stood at $139.9 million in 2020, then soared by 83.98% to $257.3 million in 2021, then climbed by 8.54% to $279.3 million in 2022, then decreased by 18.78% to $226.9 million in 2023, then fell by 25.92% to $168.1 million in 2024.